Long-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer’s disease

INTRODUCTION: CAD106 is designed to stimulate amyloid-β (Aβ)-specific antibody responses while avoiding T-cell autoimmune responses. The CAD106 first-in-human study demonstrated a favorable safety profile and promising antibody response. We investigated long-term safety, tolerability and antibody re...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Alzheimers Res Ther
Main Authors: Farlow, Martin R, Andreasen, Niels, Riviere, Marie-Emmanuelle, Vostiar, Igor, Vitaliti, Alessandra, Sovago, Judit, Caputo, Angelika, Winblad, Bengt, Graf, Ana
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2015
Fag:
Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4410460/
https://ncbi.nlm.nih.gov/pubmed/25918556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-015-0108-3
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker